Mangalam Drugs & Organics Balance Sheet Annual

Trade

BSE: 532637 | NSE: MANGALAM | ISIN: INE584F01014 | Sector: Biotechnology & Drugs

105.85 -1.05 (-0.98%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	0.01	0.47	1.43	0.08
Cash Equivalents	0.90	2.22	0.52	0.51
Short Term Investments	4.73	7.30	-	-
Cashand Short Term Investments	5.64	9.99	1.95	0.59
Accounts Receivable- Trade Net	27.94	46.53	46.49	54.31
Total Receivables Net	29.11	46.58	46.53	54.32
Total Inventory	123.64	137.47	117.11	58.59
Other Current Assets Total	17.34	12.55	16.88	20.42
Total Current Assets	175.72	206.58	182.47	133.92
Property/ Plant/ Equipment Total- Net	126.89	133.55	126.79	114.21
Intangibles Net	28.52	18.30	13.88	9.96
Long Term Investments	0.10	0.31	2.88	2.69
Other Long Term Assets Total	2.20	0.88	2.41	3.33
Total Assets	333.42	359.63	328.43	264.11
Accounts Payable	65.89	97.07	54.55	43.39
Notes Payable/ Short Term Debt	74.60	49.57	47.10	51.18
Current Portof LT Debt/ Capital Leases	5.41	13.47	10.49	8.46
Other Currentliabilities Total	17.89	5.24	17.98	6.04
Total Current Liabilities	163.79	165.36	130.11	109.08
Long Term Debt	13.35	18.77	25.10	6.88
Capital Lease Obligations	5.13	6.74	9.15	3.19
Total Long Term Debt	18.49	25.51	34.26	10.07
Total Debt	98.49	88.55	91.84	69.71
Deferred Income Tax	12.09	14.52	13.49	14.18
Other Liabilities Total	3.27	2.29	0.00	0.00
Total Liabilities	197.63	207.67	177.86	133.32
Common Stock Total	15.83	15.83	15.83	15.83
Retained Earnings( Accumulated Deficit)	119.96	113.75	112.36	92.58
Total Equity	135.79	151.96	150.56	130.79
Total Liabilities Shareholders' Equity	333.42	359.63	328.43	264.11
Total Common Shares Outstanding	1.58	1.58	1.58	1.58
Tangible Book Valueper Share Common Eq	67.77	84.44	86.36	76.34
Property/ Plant/ Equipment Total- Gross	-	223.88	208.50	187.65
Accumulated Depreciation Total	-	-90.33	-81.71	-73.43
Additional Paid- In Capital	-	22.38	22.38	22.38